Notice2022-09551
Meeting of the National Vaccine Advisory Committee
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 4, 2022
Issuing agencies
Health and Human Services Department
Abstract
As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold an in- person meeting. The meeting will be open to the public and public comment will be heard during the meeting.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 86 (Wednesday, May 4, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 86 (Wednesday, May 4, 2022)]
[Notices]
[Page 26360]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-09551]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the National Vaccine Advisory Committee
AGENCY: Office of Infectious Disease and HIV/AIDS Policy, Office of the
Assistant Secretary for Health, Office of the Secretary, Department of
Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the
Department of Health and Human Services (HHS) is hereby giving notice
that the National Vaccine Advisory Committee (NVAC) will hold an in-
person meeting. The meeting will be open to the public and public
comment will be heard during the meeting.
DATES: The meeting will be held June 15-16, 2022. The confirmed meeting
times and agenda will be posted on the NVAC website at <a href="http://www.hhs.gov/nvpo/nvac/meetings/index.html">http://www.hhs.gov/nvpo/nvac/meetings/index.html</a> as soon as they become
available.
ADDRESSES: Instructions regarding attending this meeting will be posted
online at: <a href="http://www.hhs.gov/nvpo/nvac/meetings/index.html">http://www.hhs.gov/nvpo/nvac/meetings/index.html</a> at least
one week prior to the meeting. Pre-registration is required for those
who wish to attend the meeting or participate in public comment. Please
register at <a href="http://www.hhs.gov/nvpo/nvac/meetings/index.html">http://www.hhs.gov/nvpo/nvac/meetings/index.html</a>.
FOR FURTHER INFORMATION CONTACT: Ann Aikin, Acting Designated Federal
Officer, at the Office of Infectious Disease and HIV/AIDS Policy, U.S.
Department of Health and Human Services, Mary E. Switzer Building, Room
L618, 330 C Street SW, Washington, DC 20024. Email: <a href="/cdn-cgi/l/email-protection#412f372022012929326f262e37"><span class="__cf_email__" data-cfemail="a5cbd3c4c6e5cdcdd68bc2cad3">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public
Health Service Act (42 U.S.C. 300aa-1), the Secretary of HHS was
mandated to establish the National Vaccine Program to achieve optimal
prevention of human infectious diseases through immunization and to
achieve optimal prevention against adverse reactions to vaccines. The
NVAC was established to provide advice and make recommendations to the
Director of the National Vaccine Program on matters related to the
Program's responsibilities. The Assistant Secretary for Health serves
as Director of the National Vaccine Program.
The NVAC will hear presentations on innovation for immunization,
vaccine safety, and communication, and surveillance. Please note that
agenda items are subject to change, as priorities dictate. Information
on the final meeting agenda will be posted prior to the meeting on the
NVAC website: <a href="http://www.hhs.gov/nvpo/nvac/index.html">http://www.hhs.gov/nvpo/nvac/index.html</a>.
Members of the public will have the opportunity to provide comment
at the NVAC meeting during the public comment period designated on the
agenda. Public comments made during the meeting will be limited to
three minutes per person to ensure time is allotted for all those
wishing to speak. Individuals are also welcome to submit written
comments in advance. Written comments should not exceed three pages in
length. Individuals submitting comments should email their written
comments or their request to provide a comment during the meeting to
<a href="/cdn-cgi/l/email-protection#98f6eef9fbd8f0f0ebb6fff7ee"><span class="__cf_email__" data-cfemail="29475f484a6941415a074e465f">[email protected]</span></a> at least five business days prior to the meeting.
Dated: April 5, 2022.
Ann Aikin,
Acting Designated Federal Official, Office of the Assistant Secretary
for Health.
[FR Doc. 2022-09551 Filed 5-3-22; 8:45 am]
BILLING CODE 4150-44-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on May 4, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.